Abstract
The blood–brain barrier (BBB) is a dynamic interface responsible for maintaining central nervous system (CNS) homeostasis. An intact BBB protects the brain from undesired compounds and proteins from the blood; however, BBB impairment is involved in various pathological conditions including stroke. In vivo evaluation of BBB integrity in the post-stroke brain is important for investigating stroke-induced CNS pathogenesis and developing CNS-targeted therapeutic agents. In this chapter, we describe both quantitative and morphometric methods and tools to evaluate BBB integrity in vivo. These methods do not require expensive magnetic resonance imaging (MRI) and computed tomography (CT) imaging capabilities and can be conducted in research laboratories with access to a confocal microscope and fluorescence microplate reader.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abbott NJ, Patabendige AA, Dolman DE et al (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 37:13–25
Alluri H, Grimsley M, Anasooya Shaji C et al (2016) Attenuation of blood-brain barrier breakdown and hyperpermeability by calpain inhibition. J Biol Chem 291:26958–26969
Avsenik J, Bisdas S, Popovic KS (2015) Blood-brain barrier permeability imaging using perfusion computed tomography. Radiol Oncol 49:107–114
Balda MS, Anderson JM (1993) Two classes of tight junctions are revealed by ZO-1 isoforms. Am J Phys 264:C918–C924
Balkaya M, Kim ID, Shakil F et al (2021) CD36 deficiency reduces chronic BBB dysfunction and scar formation and improves activity, hedonic and memory deficits in ischemic stroke. J Cereb Blood Flow Metab 41:486–501
Bernardo-Castro S, Sousa JA, Bras A et al (2020) Pathophysiology of blood-brain barrier permeability throughout the different stages of ischemic stroke and its implication on hemorrhagic transformation and recovery. Front Neurol 11:594672
Berndt P, Winkler L, Cording J et al (2019) Tight junction proteins at the blood-brain barrier: far more than claudin-5. Cell Mol Life Sci 76:1987–2002
Blanchette M, Daneman R (2015) Formation and maintenance of the BBB. Mech Dev 138(Pt 1):8–16
Bolton SJ, Anthony DC, Perry VH (1998) Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience 86:1245–1257
Braakman HMH, Engelen M, Nicolai J et al (2018) Stroke mimics add to the phenotypic spectrum of GLUT1 deficiency syndrome. J Neurol Neurosurg Psychiatry 89:668–670
Devraj K, Guerit S, Macas J et al (2018) An in vivo blood-brain barrier permeability assay in mice using fluorescently labeled tracers. J Vis Exp (132):57038
Furuse M, Sasaki H, Tsukita S (1999) Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol 147:891–903
Gautam J, Zhang X, Yao Y (2016) The role of pericytic laminin in blood brain barrier integrity maintenance. Sci Rep 6:36450
Georgieva JV, Hoekstra D, Zuhorn IS (2014) Smuggling drugs into the brain: an overview of ligands targeting transcytosis for drug delivery across the blood-brain barrier. Pharmaceutics 6:557–583
Ha Park J, Yoo KY, Hye Kim I et al (2016) Hydroquinone strongly alleviates focal ischemic brain injury via blockage of blood-brain barrier disruption in rats. Toxicol Sci 154:430–441
Haskins J, Gu L, Wittchen ES et al (1998) ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin. J Cell Biol 141:199–208
Hirase T, Staddon JM, Saitou M et al (1997) Occludin as a possible determinant of tight junction permeability in endothelial cells. J Cell Sci 110(Pt 14):1603–1613
Hoffmann A, Bredno J, Wendland M et al (2011) High and low molecular weight fluorescein Isothiocyanate (FITC)-dextrans to assess blood-brain barrier disruption: technical considerations. Transl Stroke Res 2:106–111
Hoffmann A, Zhu G, Wintermark M (2012) Advanced neuroimaging in stroke patients: prediction of tissue fate and hemorrhagic transformation. Expert Rev Cardiovasc Ther 10:515–524
Jiang X, Andjelkovic AV, Zhu L et al (2018) Blood-brain barrier dysfunction and recovery after ischemic stroke. Prog Neurobiol 163–164:144–171
Jiao H, Wang Z, Liu Y et al (2011) Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult. J Mol Neurosci 44:130–139
Kadry H, Noorani B, Cucullo L (2020) A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS 17:69
Kassner A, Merali Z (2015) Assessment of blood-brain barrier disruption in stroke. Stroke 46:3310–3315
Kaur C, Ling EA (2008) Blood brain barrier in hypoxic-ischemic conditions. Curr Neurovasc Res 5:71–81
Laksitorini M, Prasasty VD, Kiptoo PK et al (2014) Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers. Ther Deliv 5:1143–1163
Leino RL, Gerhart DZ, Van Bueren AM et al (1997) Ultrastructural localization of GLUT 1 and GLUT 3 glucose transporters in rat brain. J Neurosci Res 49:617–626
Liebner S, Fischmann A, Rascher G et al (2000) Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol 100:323–331
Liu F, Liu Q, Yuan F et al (2019) Erg mediates downregulation of claudin-5 in the brain endothelium of a murine experimental model of cerebral malaria. FEBS Lett 593:2585–2595
Lombardo SM, Schneider M, Tureli AE et al (2020) Key for crossing the BBB with nanoparticles: the rational design. Beilstein J Nanotechnol 11:866–883
Lu G, He Q, Shen Y et al (2018) Potential biomarkers for predicting hemorrhagic transformation of ischemic stroke. Int J Neurosci 128:79–89
Morita K, Sasaki H, Furuse M et al (1999) Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 147:185–194
Nag S (2003) Blood-brain barrier permeability using tracers and immunohistochemistry. Methods Mol Med 89:133–144
Nagaraja TN, Keenan KA, Fenstermacher JD et al (2008) Acute leakage patterns of fluorescent plasma flow markers after transient focal cerebral ischemia suggest large openings in blood-brain barrier. Microcirculation 15:1–14
Natarajan R, Northrop N, Yamamoto B (2017) Fluorescein Isothiocyanate (FITC)-dextran extravasation as a measure of blood-brain barrier permeability. Curr Protoc Neurosci 79:9.58.1–9.58.15
Pandit R, Chen L, Gotz J (2020) The blood-brain barrier: physiology and strategies for drug delivery. Adv Drug Deliv Rev 165–166:1–14
Prasad S, Sajja RK, Kaisar MA et al (2017) Role of Nrf2 and protective effects of Metformin against tobacco smoke-induced cerebrovascular toxicity. Redox Biol 12:58–69
Rajsic S, Gothe H, Borba HH et al (2019) Economic burden of stroke: a systematic review on post-stroke care. Eur J Health Econ 20:107–134
Rusu AD, Georgiou M (2020) The multifarious regulation of the apical junctional complex. Open Biol 10:190278
Sarvari S, Moakedi F, Hone E et al (2020) Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke. Metab Brain Dis 35:851–868
Saunders NR, Dziegielewska KM, Mollgard K et al (2015) Markers for blood-brain barrier integrity: how appropriate is Evans blue in the twenty-first century and what are the alternatives? Front Neurosci 9:385
Serlin Y, Shelef I, Knyazer B et al (2015) Anatomy and physiology of the blood-brain barrier. Semin Cell Dev Biol 38:2–6
Sonoda N, Furuse M, Sasaki H et al (1999) Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. J Cell Biol 147:195–204
Stevenson BR, Siliciano JD, Mooseker MS et al (1986) Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol 103:755–766
Sweeney MD, Zhao Z, Montagne A et al (2019) Blood-brain barrier: from physiology to disease and Back. Physiol Rev 99:21–78
Tajes M, Ramos-Fernandez E, Weng-Jiang X et al (2014) The blood-brain barrier: structure, function and therapeutic approaches to cross it. Mol Membr Biol 31:152–167
Tietz S, Engelhardt B (2015) Brain barriers: crosstalk between complex tight junctions and adherens junctions. J Cell Biol 209:493–506
Uldry M, Thorens B (2004) The SLC2 family of facilitated hexose and polyol transporters. Pflugers Arch 447:480–489
Xie J, Shen Z, Anraku Y et al (2019) Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. Biomaterials 224:119491
Xu Y, He Q, Wang M et al (2019) Quantifying blood-brain-barrier leakage using a combination of evans blue and high molecular weight FITC-Dextran. J Neurosci Methods 325:108349
Yang C, Hawkins KE, Dore S et al (2019) Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol 316:C135–C153
Yang L, Wang H, Shah K et al (2011) Opioid receptor agonists reduce brain edema in stroke. Brain Res 1383:307–316
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Zhang, Y., Nozohouri, S., Abbruscato, T.J. (2023). In Vivo Evaluation of BBB Integrity in the Post-stroke Brain. In: Karamyan, V.T., Stowe, A.M. (eds) Neural Repair. Methods in Molecular Biology, vol 2616. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2926-0_15
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2926-0_15
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2925-3
Online ISBN: 978-1-0716-2926-0
eBook Packages: Springer Protocols